Liver involvement in systemic lupus erythematosus: Case review of 40 patients

Journal of Rheumatology

Volumn 35, Issue 11, 2008, Pages 2159-2164

  Chowdhary, Vaidehi R ^a   Crowson, Cynthia S ^b   Poterucha, John J ^c   Moder, Kevin G ^a,d  

^a Division of Rheumatology

^b Department of Health Sciences Research ^*

^c Division of Gastroenterology and Hepatology

^d Mayo Clinic   (United States)

Author keywords

Liver disease; Prognosis; Systemic lupus erythematosus

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ERYTHROMYCIN; PHENYTOIN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; INVASIVE CANDIDIASIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER GRANULOMA; LIVER INJURY; LYMPHOMA; MALE; NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BIOPSY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 56449095648     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080336     Document Type: Article

References (37)

1. Kofman S, Johnson GC, Zimmerman HJ. Apparent hepatic dysfunction in lupus erythematosus. AMA Arch Intern Med 1955;95:669-76.
2. Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet 1959;7063:65-9.
3. Gibson T, Myers AR. Subclinical liver disease in systemic lupus erythematosus. J Rheumatol 1981;8:752-9.
4. Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. Am J Med 1980;69:187-94.
5. Miller MH, Urowitz MB, Gladman DD, Blendis LM. The liver in systemic lupus erythematosus. Q J Med 1984;53:401-9.
6. Altomonte L, Zoli A, Sommella L, Palumbo P, Greco AV, Magaro M. Concentration of serum bile acids as an index of hepatic damage in systemic lupus erythematosus. Clin Rheumatol 1984;3:209-12.
7. van Hoek B. The spectrum of liver disease in systemic lupus erythematosus. Neth J Med 1996;48:244-53.
8. Leggett BA. The liver in systemic lupus erythematosus. J Gastroenterol Hepatol 1993;8:84-8.
9. Kuramochi S, Tashiro Y, Torikata C, Watanabe Y. Systemic lupus erythematosus associated with multiple nodular hyperplasia of the liver. Acta Pathol Jpn 1982;32:547-60.
10. Klemp P, Timme AH, Sayers GM. Systemic lupus erythematosus and nodular regenerative hyperplasia of the liver. Ann Rheum Dis 1986;45:167-70.
11. Perez Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Herrero-Beites AM. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin Arthritis Rheum 1991;21:47-54.
12. Arnett FC, Reichlin M. Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med 1995;99:465-72.
13. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991;21:55-64.
14. Hall S, Czaja AJ, Kaufman DK, Markowitz H, Ginsburg WW. How lupoid is lupoid hepatitis? J Rheumatol 1986;13:95-8.
15. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Kaw R, Gota C, Bennett A, Barnes D, Calabrese L. Lupus-related hepatitis: complication of lupus or autoimmune association? Case report and review of the literature. Dig Dis Sci 2006;51:813-8.
19. Iwai M, Harada Y, Ishii M, et al. Autoimmune hepatitis in a patient with systemic lupus erythematosus. Clin Rheumatol 2003;22:234-6.
20. Tojo J, Ohira H, Yokokawa J, et al. Autoimmune hepatitis accompanied by systemic lupus erythematosus. Intern Med 2004;43:258-62.
21. Youssef WI, Tavill AS. Connective tissue diseases and the liver. J Clin Gastroenterol 2002;35:345-9.
22. Matsumoto T, Kobayashi S, Shimizu H, et al. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000;20:366-73.
23. Irving KS, Sen D, Tahir H, Pilkington C, Isenberg DA. A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus - a retrospective review of cases. Rheumatology Oxford 2007;46:1171-3.
24. Islam S, Riordan JW, McDonald JA. Case report: a rare association of primary biliary cirrhosis and systemic lupus erythematosus and review of the literature. J Gastroenterol Hepatol 1999;14:431-5.
25. Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2004;99:1316-20.
26. Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 2006;73:633-8.
27. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.
28. Abu-Shakra M, El-Sana S, Margalith M, Sikuler E, Neumann L, Buskila D. Hepatitis B and C viruses serology in patients with SLE. Lupus 1997;6:543-4.
29. Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 2000;43:2801-6.
30. Ahmed MM, Berney SM, Wolf RE, et al. Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus. Am J Med Sci 2006;331:252-6.
31. Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005;24:178-81.
32. Wilson LE, Widman D, Dikman SH, Gorevic PD. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 2002;32:163-73.
33. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine Baltimore 2006;85:147-56.
34. Cervera R, Piette JC, Font J, et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev 2006;5:180-6.
35. Wang F, Wang CL, Tan CT, Manivasagar M. Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 1997;6:248-53.
36. Mok CC, Mak A, Chu WP, To CH, Wong SN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine Baltimore 2005;84:218-24.
37. Alarcon GS, McGwin G Jr, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001;45:191-202.